Chemicals News and Research

RSS

Study shows why COVID-19 has widely varying outcomes in different people

The answer is something infectious disease experts are working to uncover. As COVID-19 revealed, the same pathogen can have widely varying outcomes in different people.

7 Jun 2021

Maternal SARS-CoV-2 infection imprints immune response in the newborn

A new bioRxiv* preprint reports the immunological footprint in the newborn left by maternal infection with SARS-CoV-2 during pregnancy.

4 Jun 2021

Mast cell activation may underlie inflammation in severe COVID-19

A new preprint research paper posted to the medRxiv* server points to mast cells as major culprits in the etiology of severe and critical COVID-19. This could suggest suitable therapeutic and preventive interventions to reduce the morbidity and mortality of this viral illness.

3 Jun 2021

Zebrafish study shows how early exposure to cannabinoids reduces later neural activity

Zebrafish exposed to the leading cannabinoids found in cannabis in the earliest stages of development suffer a significant drop in neural activity later in life, according to a University of Alberta study that has implications for prenatal development in humans.

2 Jun 2021

Could higher carnitine levels in the blood protect against severe COVID-19?

Researchers at the MRC Integrative Epidemiology Unit (IEU), Bristol Medical School, University of Bristol, Bristol, UK, found that carnitine and its derivative acetyl-carnitine provide a protective effect against severe COVID-19. Doubling of carnitine or acetyl-carnitine is tied to a 40-percent reduction risk of disease progression.

2 Jun 2021

Low levels of BPA exposure can affect prenatal brain development

Humans are exposed to a bath of chemicals every day. They are in the beds where we sleep, the cars that we drive and the kitchens we use to feed our families.

1 Jun 2021

New study to explore the health risks of nanoplastics

Nanoplastics--tiny plastic particles invisible to the naked eye--may exert an effect on nervous, immune, and reproductive systems of humans.

1 Jun 2021

Cancer risk increases with the number of cigarettes smoked per day, confirms study

Today, in advance of World No Tobacco Day, The Daffodil Centre released an Australian first study, with findings showing tobacco smoking significantly increased the risk of 12 types of cancer and that 1-in-7 current smokers will get lung cancer in their lifetime.

29 May 2021

Study explains why the same exercise have different effects in different people

Although everyone can benefit from exercise, the mechanistic links between physical fitness and overall health are not fully understood, nor are the reasons why the same exercise can have different effects in different people.

27 May 2021

New microbial genes responsible for bile acid conversion is a major step forward for gut health

As the owner of a human body, you're carrying trillions of microbes with you everywhere you go. These microscopic organisms aren't just hitching a ride; many of them perform essential chemical reactions that regulate everything from our digestion to our immune system to our moods.

27 May 2021

New porous biomaterial could help in bone repair

Scientists at Nanyang Technological University, Singapore (NTU Singapore) have developed a new biomaterial made entirely from discarded bullfrog skin and fish scales that could help in bone repair.

27 May 2021

Toxic man-made chemicals that end up in the environment highlight regulation challenges

Researchers at the University of New Hampshire have conducted two of the first studies in New England to collectively show that toxic man-made chemicals called PFAS (per-and polyfluoroalkyl substances), found in everything from rugs to product packaging, end up in the environment differently after being processed through wastewater treatment facilities--making it more challenging to set acceptable screening levels.

27 May 2021

New models can help assess how emerging contaminants disperse, impact water quality

In the last year, one thing has become clear: we cannot live life without risk. In fact, every part of our daily routines became subject to analysis: How risky is the action and is its value worth the potential cost?

26 May 2021

Scientists propose new strategies to find drugs that neutralize critical enzymes

Scientists from the University of Bath explore racemases and propose strategies for finding drugs that target these important enzymes.

26 May 2021

Researchers uncover differences in itch mechanisms

Chronic skin itching drives more people to the dermatologist than any other condition. In fact, the latest science literature finds that 7% of U.S. adults, and between 10 and 20% of people in developed countries, suffer from dermatitis, a common skin inflammatory condition that causes itching.

21 May 2021

Metal complexes against coronavirus

The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused more than 3.42 million deaths worldwide. Despite the fact that there are vaccines for SARS-CoV-2, the emergence of new variants and the lack of adequate treatments have encouraged the search for new ways to combat this disease more effectively.

21 May 2021

Plastic chemicals can induce changes in gene that is vital for neurological development

The chemical bisphenol F (found in plastics) can induce changes in a gene that is vital for neurological development. This discovery was made by researchers at the universities of Uppsala and Karlstad, Sweden.

20 May 2021

Exposure to widely used herbicides is significantly associated with preterm births, finds study

Exposure to a chemical found in the weed killer Roundup and other glyphosate-based herbicides is significantly associated with preterm births, according to a new University of Michigan study.

19 May 2021

Survey shows racial and ethnic differences in use of personal care products

A large survey of women in California shows significant racial and ethnic differences in the types of personal care products women use on a daily basis.

19 May 2021

Genetic mutation associated with autism can impair oxytocin-mediated social behavior

Autism spectrum disorder is a neurodevelopmental condition involving impaired social abilities, and this makes it a fascinating subject for neuroscientists like Prof. Teiichi Furuichi of the Tokyo University of Science who study the neuroscience of social behavior.

19 May 2021

Chemicals News and Research

Study shows why COVID-19 has widely varying outcomes in different people

Maternal SARS-CoV-2 infection imprints immune response in the newborn

Mast cell activation may underlie inflammation in severe COVID-19

Zebrafish study shows how early exposure to cannabinoids reduces later neural activity

Could higher carnitine levels in the blood protect against severe COVID-19?

Low levels of BPA exposure can affect prenatal brain development

New study to explore the health risks of nanoplastics

Cancer risk increases with the number of cigarettes smoked per day, confirms study

Study explains why the same exercise have different effects in different people

New microbial genes responsible for bile acid conversion is a major step forward for gut health

New porous biomaterial could help in bone repair

Toxic man-made chemicals that end up in the environment highlight regulation challenges

New models can help assess how emerging contaminants disperse, impact water quality

Scientists propose new strategies to find drugs that neutralize critical enzymes

Researchers uncover differences in itch mechanisms

Metal complexes against coronavirus

Plastic chemicals can induce changes in gene that is vital for neurological development

Exposure to widely used herbicides is significantly associated with preterm births, finds study

Survey shows racial and ethnic differences in use of personal care products

Genetic mutation associated with autism can impair oxytocin-mediated social behavior

Latest eBooks

Industry Focus eBook - Analytical Chemistry (3rd edition)

Industry Focus eBook - Microbiome (1st edition)

Industry Focus eBook - Cell biology (5th edition)

Advancing degrader and proximity-based drug development

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo